Pierrepont Therapeutics
Brooklyn, US · Founded 2020 · Delaware corporation
Find your way into Pierrepont Therapeutics
Sign up to see every warm intro you have to Pierrepont Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pierrepont Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MW
Matthew WyckoffNamed on SEC filing
PH
Peter H. BarberNamed on SEC filing
DD
Daniel DiPietroNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2024
▶$2.4MraisedSep 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedSep 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter H. BarberExecutive Officer, Director
- Daniel DiPietroDirector
- Matthew WyckoffDirector
- Offering amount
- $5.9M
- Amount sold
- $2.4M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pierrepont Therapeutics raised?
- Pierrepont Therapeutics has disclosed $2.4M raised across 1 round.
- Where is Pierrepont Therapeutics headquartered?
- Pierrepont Therapeutics is headquartered in Brooklyn, US.